PF-06372865
| Catalog Number | Pack Size | List Price* | Quantity | |
|---|---|---|---|---|
| HY-120874-5MG | 5 mg | 165,00 | Add | |
| HY-120874-10MMO | 10mM/1mL | 181,00 | Add | |
| HY-120874-10MG | 10 mg | 254,00 | Add | |
| HY-120874-25MG | 25 mg | 495,00 | Add | |
| HY-120874-50MG | 50 mg | 783,00 | Add | |
| HY-120874-100MG | 100 mg | 1'248,00 | Add | |
| HY-120874-S-1ST | Sample | Inquire |
* CHF, excl. 8.1% VAT and shipping costs
Product Description
Best price guarantee – we offer you the lowest price in Switzerland. Please contact us for a quote if needed.
PF-06372865 is an orally active, α2/α3/α5 subtype-selective GABAA positive allosteric modulator (PAM). PF-06372865 is a high affinity ligand at GABAA receptors containing α1/α2/α3/α5 subunits (Kis of 2.9 nM, 21 nM, 134 nM for α2, α1 PAM, α2 PAM, respectively), with low affinity for α4/α6 subunits. PF-06372865 can across the blood-brain barrier (BBB). PF-06372865 has anxiolytic activity and has the potential for epilepsy[1].
| Category | Biochemicals |
| Supplier | MedChem Express |
| Regulatory Status | RUO |
| Research Field | Neurological Disease, Membrane Transporter/Ion Channel,Neuronal Signaling |
| Format | Solubility: DMSO : 50 mg/mL (ultrasonic) |
| Grade | Clinical information: Phase 2 |
| Purity | 98.42% |
| Molecular Formula | C22H21FN4O3S |
| Molecular Weight | 440.49 |
| CAS-Number | 1614245-70-3 |
| Storage Conditions | 4°C (Powder, protect from light) |
| Tech. Data Sheet | View datasheet |
| Link To Supplier | http://www.medchemexpress.com |
| Shipping Details | Room Temperature |
| Material Safety Data Sheet | Download PDF |
